Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

This publication has 33 references indexed in Scilit:

• ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
  European Heart Journal, 2011
• Statins in women for primary prevention – is there evidence to back up their use??
  Climacteric, 2010
• Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
  The Lancet, 2010
• Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
  International Journal of Cardiology, 2010
• Status of Women in Cardiovascular Clinical Trials
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2009
• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
  New England Journal of Medicine, 2008
• Statins and Adverse Cardiovascular Events in Moderate-Risk Females: A Statistical and Legal Analysis with Implications for FDA Preemption Claims
  Journal of Empirical Legal Studies, 2008
• Rosuvastatin in Older Patients with Systolic Heart Failure
  New England Journal of Medicine, 2007
• Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): Characteristics of a randomized trial among 12064 myocardial infarction survivors
  American Heart Journal, 2007
• Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study
  American Heart Journal, 2003